Excessive inflammation can lead to metabolic diseases, such as obesity and hyperlipidemia.[45] When the intestinal barrier is damaged, LPS enters the circulation and activates the TLR4-NF-κB-IL-1b/IL-6/TNF-ɑ axis to release inflammatory cytokines. Here, NFKB1 is linked to hyperlipidemia.